Terms: = Leukemia AND TRA AND Treatment
20 results:
1. Risk Factors for treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
2. trametinib enhances Atra-induced differentiation in AML cells.
Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
[TBL] [Abstract] [Full Text] [Related]
3. Chromosome translocation t(14;21)(q11;q22) Activates Both
Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
[TBL] [Abstract] [Full Text] [Related]
4. High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies.
Komkov A; Miroshnichenkova A; Nugmanov G; Popov A; Pogorelyy M; Zapletalova E; Jelinkova H; Pospisilova S; Lebedev Y; Chudakov D; Olshanskaya Y; Plevova K; Maschan M; Mamedov I
Br J Haematol; 2020 Mar; 188(5):723-731. PubMed ID: 31587259
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors.
Nijenhuis CM; Hellriegel E; Beijnen JH; Hershock D; Huitema AD; Lucas L; Mergui-Roelvink M; Munteanu M; Rabinovich-Guilatt L; Robertson P; Rosing H; Spiegelstein O; Schellens JH
Invest New Drugs; 2016 Oct; 34(5):565-74. PubMed ID: 27221729
[TBL] [Abstract] [Full Text] [Related]
6. Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature.
Dyba J; Tinmouth A; Bredeson C; Matthews J; Allan DS
Transfus Med; 2016 Jun; 26(3):202-7. PubMed ID: 27046441
[TBL] [Abstract] [Full Text] [Related]
7. Effect of differentiating agents on interferon-gamma (INF-gamma) level in leukemic cells propagated ex-vivo.
El-Houseini ME; Amer IR; Hussein TD
J Egypt Natl Canc Inst; 2006 Dec; 18(4):283-91. PubMed ID: 18301452
[TBL] [Abstract] [Full Text] [Related]
8. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
Zhang Y; Dawson MI; Ning Y; Polin L; Parchment RE; Corbett T; Mohamed AN; Feng KC; Farhana L; Rishi AK; Hogge D; Leid M; Peterson VJ; Zhang XK; Mohammad R; Lu JS; Willman C; VanBuren E; Biggar S; Edelstein M; Eilender D; Fontana JA
Blood; 2003 Nov; 102(10):3743-52. PubMed ID: 12893763
[TBL] [Abstract] [Full Text] [Related]
9. Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia.
Jing Y; Xia L; Waxman S
Blood; 2002 Aug; 100(3):1008-13. PubMed ID: 12130515
[TBL] [Abstract] [Full Text] [Related]
10. Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.
Puccetti E; Sennewald B; Fosca-Ferrara F; Boehrer S; Bianchini A; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Hematol J; 2001; 2(6):385-92. PubMed ID: 11920278
[TBL] [Abstract] [Full Text] [Related]
11. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.
Jing Y; Wang L; Xia L; Chen GQ; Chen Z; Miller WH; Waxman S
Blood; 2001 Jan; 97(1):264-9. PubMed ID: 11133770
[TBL] [Abstract] [Full Text] [Related]
12. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.
Raelson JV; Nervi C; Rosenauer A; Benedetti L; Monczak Y; Pearson M; Pelicci PG; Miller WH
Blood; 1996 Oct; 88(8):2826-32. PubMed ID: 8874178
[TBL] [Abstract] [Full Text] [Related]
13. In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.
Jiang SY; Shyu RY; Chen HY; Lee MM; Wu KL; Yeh MY
Oncology; 1996; 53(4):334-40. PubMed ID: 8692540
[TBL] [Abstract] [Full Text] [Related]
14. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
[TBL] [Abstract] [Full Text] [Related]
15. 28-kDa mammalian heat shock protein, a novel substrate of a growth regulatory protease involved in differentiation of human leukemia cells.
Spector NL; Hardy L; Ryan C; Miller WH; Humes JL; Nadler LM; Luedke E
J Biol Chem; 1995 Jan; 270(3):1003-6. PubMed ID: 7836350
[TBL] [Abstract] [Full Text] [Related]
16. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
Skotnicki AB; Stoch A; Sacha T; Nowak WS
Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
[TBL] [Abstract] [Full Text] [Related]
17. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract] [Full Text] [Related]
18. Basophilic differentiation in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Snower D; Rubin CM; Reisel H; Variakojis D
Leukemia; 1993 Apr; 7(4):521-6. PubMed ID: 7710454
[TBL] [Abstract] [Full Text] [Related]
19. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Dulaney AM; Murgatroyd RJ
Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701
[TBL] [Abstract] [Full Text] [Related]
20. treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE
Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773
[TBL] [Abstract] [Full Text] [Related]
